Pragma Bio (former VastBiome)

Inactive

Mining the microbiome for novel products with therapeutic effect

What it does

"Pragma Bio, formerly known as VastBiome, is a pioneering company in the Food & Beverage and Health industries, focused on mining the microbiome for novel products with therapeutic effects. Utilizing deep learning, distributed supercomputing, and next-generation sequencing, Pragma Bio disrupts the drug discovery process by identifying key bacterial metabolites from the human gut microbiome. These metabolites play a crucial role in directing the host immune system and influencing outcomes in various disease indications, including autoimmune diseases and immuno-oncology. With a strong foundation in computational and experimental methods, Pragma Bio collaborates with clinical partners and has garnered interest from top pharmaceutical companies. Originating from the Texas Medical Center and Illumina Accelerator, Pragma Bio is at the forefront of developing innovative therapeutic and nutritional solutions sourced directly from patient gut microbiomes."

Next to it in Healthcare and bio · microbiome drug discovery platform

  • Numerion LabsY Combinator W15

    Artificial intelligence for drug discovery.

  • PerlaraY Combinator W16

    Perlara: building the YC for rare disease parents

  • Metagen TherapeuticsPlug and Play

    Metagen Therapeutics is a Drug discovery and medical business company which utilizes microbiome science.

  • CardiaTec BiosciencesPlug and Play

    CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.

  • Crafton Biotechnology株式会社Plug and Play

    Crafton Biotechnology Co. is a manufacturing company that researches, develops, and sells pharmaceutical products.

  • GenomeMinerPlug and Play

    GenomeMiner is a pharmaceutical company that produces medicine, agriculture, automated bioinformatics, and data management services.

  • OwkinPlug and Play

    Owkin combines life-science and machine learning expertise to make drug development and clinical trial design more targeted and more cost effective. Owkin's machine learning algorithms create models that predict disease evolution and treatment outcomes.

  • RevorfPlug and Play

    Revorf is a medical technology and drug discovery platform.